Commercially Available Enteric Empty Hard Capsules, Production Technology and Application.

ECDDT technology acid resistance commercial capsules encapsulation enteric administration hard capsules

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
13 Nov 2022
Historique:
received: 27 10 2022
revised: 09 11 2022
accepted: 11 11 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

Currently, there is a growing need to prepare small batches of enteric capsules for individual therapy or clinical evaluation since many acidic-sensitive substances should be protected from the stomach's acidic environment, including probiotics or fecal material, in the fecal microbiota transplantation (FMT) process. A suitable method seems to be the encapsulation of drugs or lyophilized alternatively frozen biological suspensions in commercial hard enteric capsules prepared by so-called Enteric Capsule Drug Delivery Technology (ECDDT). Manufacturers supply these types of capsules, made from pH-soluble polymers, in products such as AR Caps

Identifiants

pubmed: 36422528
pii: ph15111398
doi: 10.3390/ph15111398
pmc: PMC9696354
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Masaryk University
ID : MUNI/IGA/0942/2021

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Pharm Sci. 2017 Jun;106(6):1453-1465
pubmed: 28209365
Eur J Clin Nutr. 2012 Nov;66(11):1234-41
pubmed: 22990854
Int J Pharm. 2007 Dec 10;345(1-2):2-8
pubmed: 17935916
Eur J Pharm Sci. 2019 Mar 1;129:163-172
pubmed: 30639530
Pharmaceutics. 2020 Jan 19;12(1):
pubmed: 31963818
Br J Clin Pharmacol. 2022 Oct 9;:
pubmed: 36210644
Int J Pharm. 2001 Aug 14;224(1-2):19-38
pubmed: 11472812
J Infect Dis. 2016 Jul 15;214(2):173-81
pubmed: 26908752
World J Gastroenterol. 2022 Jun 21;28(23):2546-2560
pubmed: 35949351
Pharm World Sci. 2001 Oct;23(5):185-8
pubmed: 11721676
Eur J Pharm Sci. 2004 Apr;21(5):617-23
pubmed: 15066662
Biomaterials. 2010 Apr;31(12):3384-94
pubmed: 20149435
JAMA. 2014 Nov 5;312(17):1772-8
pubmed: 25322359
Drug Des Devel Ther. 2022 Mar 06;16:619-634
pubmed: 35281316
Dig Dis Sci. 2021 Feb;66(2):369-380
pubmed: 32166622
Drug Dev Ind Pharm. 2011 Oct;37(10):1131-40
pubmed: 21417619
Int J Pharm. 2022 Feb 5;613:121384
pubmed: 34919998
Pharmaceutics. 2022 Jul 29;14(8):
pubmed: 36015203
BMJ Open. 2019 Apr 20;9(4):e026174
pubmed: 31005929
Am J Clin Nutr. 2022 Mar 4;115(3):925-940
pubmed: 35102364
J Control Release. 2019 Nov 10;313:24-32
pubmed: 31626859
Eur J Pharm Sci. 2019 Oct 1;138:105019
pubmed: 31374253
J Hosp Infect. 2020 Jun;105(2):319-324
pubmed: 31883938
Am J Gastroenterol. 2017 Jun;112(6):940-947
pubmed: 28195180
PLoS One. 2018 Nov 2;13(11):e0205064
pubmed: 30388112
Eur J Pharm Biopharm. 2019 Nov;144:174-179
pubmed: 31541663
Curr Gastroenterol Rep. 2018 Jun 9;20(7):30
pubmed: 29886561
Carbohydr Polym. 2020 Feb 15;230:115617
pubmed: 31887888
Eur J Pharm Sci. 2000;10(4):267-74
pubmed: 10838016
Pharm Res. 2022 Jan;39(1):201-211
pubmed: 35043354
Therap Adv Gastroenterol. 2021 Aug 31;14:17562848211041004
pubmed: 34484424
Eur J Hosp Pharm. 2019 Jan;26(1):10-15
pubmed: 31157089
J Control Release. 2022 Oct;350:324-331
pubmed: 35963468
J Pharm Pharm Sci. 2010;13(3):428-42
pubmed: 21092714
AAPS PharmSciTech. 2021 Jan 12;22(1):44
pubmed: 33438107
BMC Infect Dis. 2015 Apr 17;15:191
pubmed: 25885020
Blood Adv. 2018 Nov 27;2(22):3097-3101
pubmed: 30446486
Pak J Pharm Sci. 2005 Jul;18(3):25-38
pubmed: 16380341
Int J Pharm. 2010 Mar 30;388(1-2):190-5
pubmed: 20079410
Medicine (Baltimore). 2018 Aug;97(31):e11706
pubmed: 30075573
Carbohydr Polym. 2013 Oct 15;98(1):73-9
pubmed: 23987318
Int J Pharm X. 2019 Jul 19;1:100024
pubmed: 31517289
Eur J Pharm Sci. 2007 Mar;30(3-4):251-5
pubmed: 17188473
Pharmaceutics. 2021 Nov 25;13(12):
pubmed: 34959284
Int J Pharm. 2018 Oct 25;550(1-2):180-189
pubmed: 30110621
Int J Pharm. 2009 Jan 21;366(1-2):185-9
pubmed: 18822363
Regul Toxicol Pharmacol. 2012 Jul;63(2):313-20
pubmed: 22561556
AAPS PharmSciTech. 2004 Oct 01;5(4):e57
pubmed: 15760054
Front Cell Infect Microbiol. 2021 Jun 04;11:657320
pubmed: 34150673
J Control Release. 2007 May 14;119(1):5-24
pubmed: 17382422
Gut. 2018 Dec;67(12):2107-2115
pubmed: 29980607
Front Immunol. 2017 Jun 12;8:655
pubmed: 28659913

Auteurs

Aleš Franc (A)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 612 42 Brno, Czech Republic.

David Vetchý (D)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 612 42 Brno, Czech Republic.

Nicole Fülöpová (N)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 612 42 Brno, Czech Republic.

Classifications MeSH